kalytera therapeutics

Taking the fun out of weed, but addressing unmet need: Startup refining cannabinoids for therapeutic use

Los Angeles startup Kalytera Therapeutics is taking the high out of the THC – refining cannabinoids so they can have broader therapeutic applications in conditions like osteoporosis, Prader-Willi syndrome, PTSD, obesity and weight loss associated with cancer. Kalytera just raised $500,000 in seed funding, according to a regulatory filing. There’s a litany of potential applications for […]